Clinical Trial Categories
Thyroid Trials
STAR 18164
Avavilable at 1 location
A Phase 1 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors
